OS Therapies IncorporatedOSTXNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+113.6%
5Y CAGR+576.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+113.6%/yr
Annual compound
5Y CAGR
+576.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14143.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$11.25M+183.0%
2024$3.97M+254.7%
2023$1.12M-2.9%
2022$1.15M-23.3%
2021$1.50M+188923.0%
2020$795.42-